Prognostic factors and outcomes in 28 cases of uterine leiomyosarcoma

Oncology

Volumn 81, Issue 2, 2011, Pages 91-97

  Loizzi, V ^a   Cormio, G ^a   Nestola, D ^a   Falagario, M ^a   Surgo, A ^a   Camporeale, A ^a   Putignano, G ^a   Selvaggi, L ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Leiomyoma; Prognostic factor; Uterine leiomyosarcomas

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; EPIRUBICIN; GEMCITABINE; IFOSFAMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; HYSTERECTOMY; LEIOMYOSARCOMA; MENOPAUSE; MYOMECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; SALPINGOOOPHORECTOMY; TREATMENT RESPONSE; UTERUS LEIOMYOSARCOMA;

ADULT; AGED; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 80054888615     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000331679     Document Type: Article

References (17)

1. Major FJ, et al.: Prognostic factors in earlystage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 1993;71(suppl 4):1702-1709. (Pubitemid 23056094)
2. D'Angelo E, Prat J: Uterine sarcomas: a review. Gynecol Oncol 2010; 116: 131-139.
3. Kim WY, et al.: Uterine leiomyosarcoma: 14- year two-center experience of 31 cases. Cancer Res Treat 2009;41:24-28.
4. Parker WH, Fu YS, Berek JS: Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994;83:414-418. (Pubitemid 24067812)
5. Gadducci A, et al.: The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 2008;65:129-142.
6. Kapp DS, Shin JY, Chan JK: Prognostic factors and survival in 1,396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 2008;112:820-830. (Pubitemid 351240576)
7. Zagouri F, et al.: Treatment of early uterine sarcomas: disentangling adjuvant modalities. World J Surg Oncol 2009;7:38.
8. Pautier P, et al.: Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 2000;88:1425-1431. (Pubitemid 30155181)
9. Larson B, et al.: Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936-1981. Acta Oncol 1990;29:185-191. (Pubitemid 20145283)
10. Hassini A, et al.: Uterine sarcomas: clinical and therapeutic aspects (10 cases). J Gynecol Obstet Biol Reprod (Paris) 2006;35:348-355. (Pubitemid 43873119)
11. Wheelock MC, Warren S: Leiomyosarcoma of the uterus. Ann Surg 1942;116:882-890.
12. King ME, Dickersin GR, Scully RE: Mixed leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 1982;6:589-598. (Pubitemid 13234756)
13. Chang E, Shim SI: Myxoid leiomyosarcoma of the uterus: a case report and review of the literature. J Korean Med Sci 1998;13:559-562. (Pubitemid 128686251)
14. Leitao MM, et al.: Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer 2004;101:1455-1462. (Pubitemid 39180402)
15. Rha SE, et al.: CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 2003;181:1369-1374. (Pubitemid 37296418)
16. Yovine A, et al.: Phase II study of ecteinascidin-743 in advanced pretreated soft tissue sarcoma patients. J Clin Oncol 2004;22:890-899. (Pubitemid 41103601)
17. Barbetakis N, et al.: Cutaneous skull metastasis from uterine leiomyosarcoma: a case report. World J Surg Oncol 2009;7:45.